文献速递头颈外科

大分割放疗方案对局部晚期头颈癌患者的影响

Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients.
PubMed 文献 · Laryngoscope · 2019-05-07

该研究纳入145例局部晚期头颈癌患者,比较两种大分割放疗方案:A组97例采用69.96/54.45 Gy分33次、5 mm margins,B组48例采用66/54 Gy分30次、3 mm margins。中位随访26个月,B组急性吞咽困难显著加重(P=0.003),A组1年和2年局部区域控制率更优(P=0.045),但DFS和OS两组无差异。

要点

  • B组(3 mm margins、66/54 Gy分30次)急性吞咽困难较A组显著加重(P=0.003)。
  • A组(5 mm margins、69.96/54.45 Gy分33次)1年和2年局部区域控制率优于B组(P=0.045)。
  • 两组DFS(P=0.270)和OS(P=0.152)无显著差异。

核心结论

  • 采用缩小的CTV-PTV margins和大分割剂量降低可改善局部晚期头颈癌患者的毒性模式,但导致局部区域进展率增加,尤其在低风险区域。

研究设计与样本

  • 研究纳入145例局部晚期头颈癌患者,分为两组:A组97例接受69.96/54.45 Gy分33次、5 mm margins;B组48例接受66/54 Gy分30次、3 mm margins。

主要发现

  • 中位随访26个月,B组急性吞咽困难较A组显著加重(P=0.003),急性唾液毒性两组差异趋于显著(P=0.071),晚期毒性无显著差异。
  • 1年和2年局部区域控制率分别为90.1%±2.6%和84.2%±3.4%,A组优于B组(P=0.045);低剂量水平差异有统计学意义(P=0.007),高剂量水平无统计学意义(P=0.110)。
  • 1年和2年无病生存率分别为84.9%±3.1%和76.5%±3.9%,总生存率分别为95.9%±1.8%和91.6%±2.7%,两组DFS(P=0.270)和OS(P=0.152)无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze two cohorts of locally advanced head and neck cancer (LAHNC) patients treated with two schedules of hypofractionated radiotherapy and 5 versus 3 mm clinical target volume-planning target volume (CTV-PTV) margins. METHODS: 145 patients were included. The patient cohort was divided into two groups. Group A included 97 patients treated with 69.96/54.45 grays (Gy) to the high-risk and low-risk volumes, respectively, in 33 fractions, with 5 mm margins. Group B included 48 patients treated with 66/54 Gy in 30 fractions using 3 mm margins. Toxicity was recorded according to the Common Toxicity Criteria version 3. Patient outcomes for locoregional control (LRC), disease-free survival (DFS), and overall survival (OS) were determined. RESULTS: Median follow-up was 26 months. In terms of toxicity, acute dysphagia worsened significantly (P = 0.003) in group B, whereas acute salivary toxicity tended to significance (P = 0.071). No significant late toxicity differences were recorded. Rates of LRC at 1 and 2 years were 90.1% ± 2.6% and 84.2% ± 3.4%, respectively, with superiority for group A (P = 0.045). The statistical significance remained for the low-dose level (P = 0.007) but not for high dose (P = 0.110). Rates of DFS at 1 and 2 years were 84.9% ± 3.1% and 76.5% ± 3.9%, respectively, whereas rates of OS were 95.9% ± 1.8% and 91.6% ± 2.7%, respectively. No differences were observed between the two groups in terms of DFS (P = 0.270) and OS (P = 0.152). CONCLUSION: The use of reduced CTV to PTV margins and dose reduction with hypofractionation schedule can improve the pattern of toxicity in LAHNC patients. This approach resulted in an increased rate of locoregional progression, particularly in low-risk regions. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:E163-E170, 2020.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Franzese C, Fogliata A, Franceschini D, et al. Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients. Laryngoscope. 2019. PMID: 31063588. doi:10.1002/lary.28048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。